Induction therapy with cetuximab plus docetaxel, cisplatin, and 5‐fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO‐07 study

Publisher： John Wiley & Sons Inc

E-ISSN： 2045-7634|4|5|721-731

ISSN： 2045-7634

Source： Cancer Medicine, Vol.4, Iss.5, 2015-05, pp. : 721-731

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck

By Tsukuda Mamoru   Mikami Yasukazu   Tanigaki Yuji   Katori Hideaki   Horiuchi Choichi   Ikeda Yoichi   Taguchi Takahide   Ono Machiko   Yoshida Takahumi   Sakuma Yasunori   Aikoh Ken  

International Journal of Clinical Oncology, Vol. 9, Iss. 3, 2004-06 ,pp. : 161-166

Springer Publishing Company

Access to resources Recommend Favorite

Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study

By Tanaka Yoshihiro   Yoshida Kazuhiro   Sanada Yuichi   Osada Shinji   Yamaguchi Kazuya   Takahashi Takao  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1159-1165

Springer Publishing Company

Access to resources Recommend Favorite

Dose escalation study of docetaxel and nedaplatin in patients with relapsed or refractory squamous cell carcinoma of the esophagus pretreated using cisplatin, 5-fluorouracil, and radiation

By Yoshioka Takashi   Sakayori Masato   Kato Shunsuke   Chiba Natsuko   Miyazaki Shukichi   Nemoto Kenji   Shibata Hiroyuki   Shimodaira Hideki   Ohtsuka Kazunori   Kakudo Yuichi   Sakata Yuh   Ishioka Chikashi  

International Journal of Clinical Oncology, Vol. 11, Iss. 6, 2006-12 ,pp. : 454-460

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of docetaxel, cisplatin and S1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma

By                      

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 898-904

Spandidos Publications

Access to resources Recommend Favorite

Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients

By                  

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 446-452

Spandidos Publications

Access to resources Recommend Favorite